Anticholinergics Associated with Longer Hospital Stays
the Psychiatry Advisor take:
Anticholinergic drugs, commonly used to treat conditions ranging from bladder problems to depression and insomnia, can cause cognitive impairment that may interfere with rehabilitation efforts and prolong hospital stay for patients recovering from brain and spinal chord injuries.
Researchers from the British National Health Service and Aston University's School of Life & Health Sciences in the United Kingdom examined the way the side effects of anticholinergics impacted 52 patients with brain or spinal injury being treated at a neuro-rehabilitation unit.
The average length of hospital stay was longer among those with higher levels of anticholinergic drug burden (ACB) and shorter among those with lower ACB, the researchers found.
"This pilot study demonstrates the need for larger studies to confirm the results and need for further investigation into what long-term effects these common medications are having on the recovery of these patients," the researchers wrote.
In addition to the clinical implications on patient quality of life such findings may have, patient discharge rates are often tied to financial incentives for hospitals, raising questions about wider efficiencies in the healthcare system.
Anticholinergics may delay recovery from brain injury.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Amisulpride May Be Most Effective Antipsychotic for Negative Symptoms in Schizophrenia
- Frustrations With Prior Authorization: A Thorn in the Side of Clinicians
- Efficacy of Drugs for Psychosis, Relapse Prevention for Bipolar Depression, Mania
- No Evidence of Cognitive Impairment With Lisdexamfetamine Dimesylate in ADHD
- Plasma Autoantibodies Possible Biomarker for Schizophrenia
- Substance-Induced Psychosis Associated With Development of Schizophrenia, Bipolar Disorder
- Neuropsychiatric Events May Be Linked to Nitrated Nucleosome Levels in Lupus
- New APA Guideline Recommendation for Treatment of Alcohol Use Disorder
- Reducing PTSD Symptoms: Propranolol Before Reactivation Therapy
- Cannabis Use Associated With Subsequent Psychotic Experiences in Adolescents
- Cognitive Enhancement Therapy Beneficial for Neurocognitive Function in Autism
- The Crisis of Physician Suicides: Past and Present
- Affective Temperaments in Bipolar Have a Significant Impact on Functional, Clinical Outcomes of Mania
- Ketamine: A Promising Agent for Managing Treatment-Resistant Depression
- Patterns of Healthcare Use Before Diagnosis of Psychotic Disorders in Young Adults